|
[1]
|
Global Initiative for Chronic Obstructive Lung Disease (2021) Global Strategy for the Diagnosis, Management, and Pre-vention of Chronic Obstructive Pulmonary Disease. Report.
|
|
[2]
|
Touchberry, C.D., Green, T.M., Tchikrizov, V., et al. (2013) FGF23 Is a Novel Regulator of Intracellular Calcium and Cardiac Contractility in Addition to Cardiac Hypertro-phy. American Journal of Physiology-Endocrinology and Metabolism, 304, E863-E873. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kanbay, M., Vervloet, M., Cozzolino, M., et al. (2017) Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hy-pertrophy, Proteinuria and Acute Kidney Injury. Calcified Tissue International, 100, 217-228. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Richter, B. and Faul, C. (2018) FGF23 Actions on Target Tissues with and without Klotho. Frontiers in Endocrinology (Lausanne), 9, 189. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Mirams, M., Robinson, B.G., Mason, R.S., et al. (2004) Bone as a Source of FGF23: Regulation by Phosphate? Bone, 35, 1192-1199. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Martin, A., David, V. and Quarles, L.D. (2012) Regulation and Function of the FGF23/Klotho Endocrine Pathways. Physiological Reviews, 92, 131-155. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chen, G., Liu, Y., Goetz, R., et al. (2018) α-Klotho Is a Non-Enzymatic Molecular Scaffold for FGF23 Hormone Signalling. Nature, 553, 461-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kuro, O.M., Matsumura, Y., Aizawa, H., et al. (1997) Mutation of the Mouse Klotho Gene Leads to a Syndrome Resembling Ageing. Nature, 390, 45-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Hu, M.C., Shiizaki, K., Kuro, O.M., et al. (2013) Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism. Annual Review of Physi-ology, 75, 503-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Yamamoto, M., Clark, J.D., Pastor, J.V., et al. (2005) Regulation of Oxidative Stress by the Anti-Aging Hormone Klotho. Journal of Biological Chemistry, 280, 38029-38034. [Google Scholar] [CrossRef]
|
|
[11]
|
Zeng, Y., Wang, P.H., Zhang, M., et al. (2016) Aging-Related Renal Injury and Inflammation Are Associated with Downregulation of Klotho and Induction of RIG-I/NF-κB Signaling Path-way in Senescence-Accelerated Mice. Aging Clinical and Experimental Research, 28, 69-76. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Ravikumar, P., Ye, J., Zhang, J., et al. (2014) α-Klotho Protects against Oxidative Damage in Pulmonary Epithelia. The American Journal of Physiology-Lung Cellular and Molecular Physiology, 307, L566-L575. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Smith, R.C., O’bryan, L.M., Farrow, E.G., et al. (2012) Circulat-ing α-Klotho Influences Phosphate Handling by Controlling FGF23 Production. Journal of Clinical Investigation, 122, 4710-4715. [Google Scholar] [CrossRef]
|
|
[14]
|
Hum, J.M., O’bryan, L., Smith, R.C., et al. (2017) Novel Func-tions of Circulating Klotho. Bone, 100, 36-40. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Grabner, A., Amaral, A.P., Schramm, K., et al. (2015) Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metabolism, 22, 1020-1032. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Faul, C., Amaral, A.P., Oskouei, B., et al. (2011) FGF23 Induces Left Ventricular Hypertrophy. Journal of Clinical Investigation, 121, 4393-4408. [Google Scholar] [CrossRef]
|
|
[17]
|
Singh, S., Grabner, A., Yanucil, C., et al. (2016) Fibroblast Growth Factor 23 Directly Targets Hepatocytes to Promote Inflammation in Chronic Kidney Disease. Kidney International, 90, 985-996. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Krick, S., Grabner, A., Baumlin, N., et al. (2018) Fibroblast Growth Factor 23 and Klotho Contribute to Airway Inflammation. European Respiratory Journal, 52, Article ID: 1800236. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Weinstein, M., Xu, X., Ohyama, K., et al. (1998) FGFR-3 and FGFR-4 Function Cooperatively to Direct Alveogenesis in the Murine Lung. Development, 125, 3615-3623. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Krick, S., Garth, J., Helton, S.E., et al. (2019) Cigarette Smoke Can Activate Fibroblast Growth Factor Signaling in Vascular Smooth Muscle Cells in the COPD Lung. American Journal of Respiratory and Critical Care Medicine, 199, A4518. [Google Scholar] [CrossRef]
|
|
[21]
|
(2014) In Exacerbations, Timely Consideration of an ICS/LABA Combination. MMW Fortschritte der Medizin, 156, 66. [Google Scholar] [CrossRef]
|
|
[22]
|
Krick, S., Helton, E.S., Hutcheson, S.B., et al. (2018) FGF23 In-duction of O-Linked N-Acetylglucosamine Regulates IL-6 Secretion in Human Bronchial Epithelial Cells. Frontiers in Endocrinology (Lausanne), 9, 708. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ishii, T., Kida, K. and Gemma, A. (2013) The Effect of Senescence on COPD Pathogenesis: Involvement of Telomere and an Antiaging Molecule Fibroblast Growth Factor 23. American Journal of Respiratory and Critical Care Medicine, 187, A2749.
|
|
[24]
|
Rahman, I. and Adcock, I.M. (2006) Oxidative Stress and Redox Regulation of Lung Inflammation in COPD. European Respiratory Journal, 28, 219-242. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Gao, W., Yuan, C., Zhang, J., et al. (2015) Klotho Expression Is Reduced in COPD Airway Epithelial Cells: Effects on Inflammation and Oxidant Injury. Clinical Science (London), 129, 1011-1023. [Google Scholar] [CrossRef]
|
|
[26]
|
Li, L., Wang, Y., Gao, W., et al. (2015) Klotho Reduc-tion in Alveolar Macrophages Contributes to Cigarette Smoke Extract-Induced Inflammation in Chronic Obstructive Pulmonary Disease. Journal of Biological Chemistry, 290, 27890-27900. [Google Scholar] [CrossRef]
|
|
[27]
|
Shapiro, S.D. (1999) The Macrophage in Chronic Obstructive Pul-monary Disease. American Journal of Respiratory and Critical Care Medicine, 160, S29-S32. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Rajendrasozhan, S., Yang, S.R., Kinnula, V.L., et al. (2008) SIRT1, an Antiinflammatory and Antiaging Protein, Is Decreased in Lungs of Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 177, 861-870. [Google Scholar] [CrossRef]
|
|
[29]
|
Baeuerle, P.A. and Henkel, T. (1994) Function and Activation of NF-kappaB in the Immune System. Annual Review of Immunology, 12, 141-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Huang, T.T. and Miyamoto, S. (2001) Postrepression Activation of NF-kappaB Requires the Amino-Terminal Nuclear Export Signal Specific to IkappaB Alpha. Molecular and Cellular Biology, 21, 4737-4747. [Google Scholar] [CrossRef]
|
|
[31]
|
Qiu, J., Zhang, Y.N., Zheng, X., et al. (2018) Notch Promotes DNMT-Mediated Hypermethylation of Klotho Leads to COPD-Related Inflammation. Experimental Lung Re-search, 44, 368-377. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Summaries for patients. Effect of Treatment with Fluticasone with and without Salmeterol on Airway Inflammation and Lung Function in Patients with Chronic Obstructive Pulmo-nary Disease: A Randomized Trial. Annals of Internal Medicine, 151, I21.
|
|
[33]
|
(2018) ISPOR Europe 2018: New Per-spectives for Improving 21st Century Health Systems. Value in Health, 21, S1-S498.
|
|
[34]
|
Faner, R., Rojas, M., Macnee, W., et al. (2012) Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 186, 306-313. [Google Scholar] [CrossRef]
|
|
[35]
|
Tsuji, T., Aoshiba, K. and Nagai, A. (2004) Cigarette Smoke Induces Senescence in Alveolar Epithelial Cells. The American Journal of Respiratory Cell and Molecular Biology, 31, 643-649. [Google Scholar] [CrossRef]
|
|
[36]
|
Kumar, M., Seeger, W. and Voswinckel, R. (2014) Senes-cence-Associated Secretory Phenotype and Its Possible Role in Chronic Obstructive Pulmonary Disease. The American Journal of Respiratory Cell and Molecular Biology, 51, 323-333. [Google Scholar] [CrossRef]
|
|
[37]
|
Tuder, R.M., Yun, J.H. and Graham, B.B. (2008) Cigarette Smoke Triggers Code Red: p21CIP1/WAF1/SDI1 Switches on Danger Responses in the Lung. The American Journal of Res-piratory Cell and Molecular Biology, 39, 1-6. [Google Scholar] [CrossRef]
|
|
[38]
|
De Oliveira, R.M. (2006) Klotho RNAi Induces Premature Se-nescence of Human Cells via a p53/p21 Dependent Pathway. FEBS Letters, 580, 5753-5758. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Blake, D.J., Reese, C.M., Garcia, M., et al. (2015) Soluble Ex-tracellular Klotho Decreases Sensitivity to Cigarette Smoke Induced Cell Death in Human Lung Epithelial Cells. Toxicol-ogy in Vitro, 29, 1647-1652. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Chen, Z.H., Kim, H.P., Sciurba, F.C., et al. (2008) Egr-1 Regulates Autophagy in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease. PLOS ONE, 3, e3316. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Monick, M.M., Powers, L.S., Walters, K., et al. (2010) Identi-fication of an Autophagy Defect in Smokers’ Alveolar Macrophages. The Journal of Immunology, 185, 5425-5435. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Li, L., Zhang, M., Zhang, L., et al. (2017) Klotho Regulates Ciga-rette Smoke-Induced Autophagy: Implication in Pathogenesis of COPD. Lung, 195, 295-301. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Fiaccadori, E., Coffrini, E., Ronda, N., et al. (1990) Hypophos-phatemia in Course of Chronic Obstructive Pulmonary Disease. Prevalence, Mechanisms, and Relationships with Skeletal Muscle Phosphorus Content. Chest, 97, 857-868. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Farah, R., Khamisy-Farah, R., Arraf, Z., et al. (2013) Hypophos-phatemia as a Prognostic Value in Acute Exacerbation of COPD. The Clinical Respiratory Journal, 7, 407-415. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Fiaccadori, E., Coffrini, E., Fracchia, C., et al. (1994) Hypophosphatemia and Phosphorus Depletion in Respiratory and Peripheral Muscles of Patients with Respiratory Failure Due to COPD. Chest, 105, 1392-1398. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Elsammak, M., Attia, A. and Suleman, M. (2012) Fibroblast Growth Factor-23 and Hypophosphatemia in Chronic Obstructive Pulmonary Disease Patients. Journal of Medical Biochemistry, 31, 12-18. [Google Scholar] [CrossRef]
|
|
[47]
|
Stroda, A., Brandenburg, V., Daher, A., et al. (2018) Serum Phosphate and Phosphate-Regulatory Hormones in COPD Patients. Respiratory Research, 19, 183. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Kraen, M., Frantz, S., Nihlen, U., et al. (2021) Fibroblast Growth Factor 23 Is an Independent Marker of COPD and Is Associated with Impairment of Pulmonary Function and Diffusing Capacity. Respiratory Medicine, 182, Article ID: 106404. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Madani, A., Zanen, J., De Maertelaer, V. and Gevenois, P.A. (2006) Pulmonary Emphysema: Objective Quantification at Mul-ti-Detector Row CT—Comparison with Macroscopic and Microscopic Morphometry. Radiology, 238, 1036-1043. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Gulati, S., Wells, J.M., Urdaneta, G.P., et al. (2019) Fibroblast Growth Factor 23 Is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study. In-ternational Journal of Molecular Sciences, 20, 2292. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Pako, J., Barta, I., Balogh, Z., et al. (2017) Assessment of the An-ti-Aging Klotho Protein in Patients with COPD Undergoing Pulmonary Rehabilitation. COPD, 14, 176-180. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Boeselt, T., Nell, C., Lütteken, L., et al. (2017) Benefits of High-Intensity Exercise Training to Patients with Chronic Obstructive Pulmonary Disease: A Controlled Study. Respira-tion, 93, 301-310. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Patel, M.S., Donaldson, A.V., Lewis, A., et al. (2016) Klotho and Smoking—An Interplay Influencing the Skeletal Muscle Function Deficits That Occur in COPD. Respiratory Medicine, 113, 50-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Hagel, M., Miduturu, C., Sheets, M., et al. (2015) First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway. Cancer Discovery, 5, 424-437. [Google Scholar] [CrossRef]
|